EBV Infection in XLP1 Manifested Solely by Behavioral Aggression and Effective Treatment Using Rituximab

Figure 2

EBV copies remained at nearly 1000 per mL in peripheral blood after a 2-week treatment combination of IVIG and antivirals. EBV copies were reduced drastically with the first dose of rituximab and became undetectable following the second dose.